Millennium Management’s Viking Therapeutics VKTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$25M Buy
941,937
+689,292
+273% +$18.3M 0.01% 979
2025
Q1
$6.1M Buy
252,645
+149,913
+146% +$3.62M ﹤0.01% 1837
2024
Q4
$4.13M Sell
102,732
-69,590
-40% -$2.8M ﹤0.01% 2115
2024
Q3
$10.9M Sell
172,322
-550,692
-76% -$34.9M 0.01% 1497
2024
Q2
$38.3M Buy
723,014
+325,925
+82% +$17.3M 0.02% 687
2024
Q1
$32.6M Sell
397,089
-5,767
-1% -$473K 0.01% 770
2023
Q4
$7.5M Sell
402,856
-1,189,838
-75% -$22.1M ﹤0.01% 1650
2023
Q3
$17.6M Sell
1,592,694
-230,426
-13% -$2.55M 0.01% 1036
2023
Q2
$29.6M Sell
1,823,120
-2,014,876
-52% -$32.7M 0.01% 766
2023
Q1
$63.9M Sell
3,837,996
-544,504
-12% -$9.07M 0.04% 373
2022
Q4
$41.2M Buy
4,382,500
+1,279,469
+41% +$12M 0.02% 566
2022
Q3
$8.44M Buy
3,103,031
+1,788,275
+136% +$4.86M 0.01% 1753
2022
Q2
$3.8M Sell
1,314,756
-187,130
-12% -$541K ﹤0.01% 2380
2022
Q1
$4.51M Buy
1,501,886
+1,296,236
+630% +$3.89M ﹤0.01% 2380
2021
Q4
$946K Buy
205,650
+146,442
+247% +$674K ﹤0.01% 3528
2021
Q3
$372K Buy
59,208
+11,532
+24% +$72.5K ﹤0.01% 4381
2021
Q2
$286K Buy
+47,676
New +$286K ﹤0.01% 4534
2020
Q4
Sell
-35,091
Closed -$204 4408
2020
Q3
$204 Sell
35,091
-365,603
-91% -$2.13K ﹤0.01% 3245
2020
Q2
$2.89M Buy
400,694
+353,447
+748% +$2.55M ﹤0.01% 1795
2020
Q1
$221K Buy
+47,247
New +$221K ﹤0.01% 2685
2019
Q4
Sell
-169,070
Closed -$1.16M 3827
2019
Q3
$1.16M Buy
+169,070
New +$1.16M ﹤0.01% 2250
2019
Q1
Sell
-82,900
Closed -$634K 3736
2018
Q4
$634K Sell
82,900
-286,516
-78% -$2.19M ﹤0.01% 2476
2018
Q3
$6.44M Sell
369,416
-371,188
-50% -$6.47M 0.01% 1443
2018
Q2
$7.03M Sell
740,604
-658,766
-47% -$6.25M 0.01% 1414
2018
Q1
$6.12M Buy
1,399,370
+696,398
+99% +$3.04M 0.01% 1568
2017
Q4
$2.85M Buy
+702,972
New +$2.85M ﹤0.01% 1920